Business
bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation
SAN ANTONIO, January 07, 2026--bioAffinity's laboratory, Precision Pathology Laboratory Services, maintains accreditation from the College of American Pathologists
About this update from Bioaffinity Technologies, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":201,"url":"https://media.zenfs.com/en/business-wire.com/d95df7a691b5787ae11f230493dd9c94"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BJ457j5D2AypFzg1RrWzbw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQwMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d95df7a691b5787ae11f230493dd9c94","width":480,"height":201}},"lazy":false},{"type":"text","content":"CyPath® Lung addresses urgent unmet need in projected $10.4 billion lung cancer diagnostic market by 2034","length":105,"tagName":"p","attribs":{}},{"type":"text","content":"Precision Pathology Laboratory Services meets gold standard for excellence across all laboratory service lines","length":110,"tagName":"p","attribs":{}},{"type":"text","content":"CAP accreditation reaffirms CyPath® Lung test’s highest standards of quality, accuracy and patient safety","length":105,"tagName":"p","attribs":{}},{"type":"text","content":"SAN ANTONIO, January 07, 2026--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that its wholly owned laboratory subsidiary, Precision Pathology Laboratory Services (PPLS), has successfully maintained its accreditation from the College of American Pathologists (CAP) following a rigorous on-site inspection.","length":432,"tagName":"p"},{"type":"text","content":"Considered the gold standard in laboratory quality, CAP accreditation signifies that a laboratory meets high standards of quality, accuracy and patient safety through comprehensive peer-based inspections conducted every two years.","length":230,"tagName":"p"},{"type":"text","content":""Earning CAP accreditation is a significant achievement and a testament to our laboratory team’s commitment to the highest standards in laboratory medicine," said Xavier T. Reveles, MS, Chief Operating Officer of bioAffinity Technologies and PPLS. "This accreditation highlights our dedication to quality, accuracy and patient safety while delivering reliable diagnostic services, including our noninvasive CyPath® Lung test, in support of better patient outcomes. We are proud of our team for consistently exceeding these rigorous standards."...